HHEX and prostate cancer: CK2-dependent phosphorylation of PRH not only results in the inhibition of PRH DNA-binding activity, increased cleavage of PRH by the proteasome, and the dysregulation of PRH target genes [76,78] but also in increased cell proliferation and tumor cell migration and invasion as shown in prostate cancer cells [77].